Skip to content

Ellipsys Vascular Access System AMI6005 (REF AMI6005 CE)Recalls & reported problems

Avenu Medical, Inc. · The Ellipsys® Vascular Access System is indicated for the creation of a proximal radial artery to perforating vein anastomosis via a retrograde venous access approach in patients with a minimum vessel diameter of 2.0mm and less than 1.5mm of separation between the artery and vein at the fistula creation site who have chronic kidney disease requiring dialysis. The main components of the Ellipsys Vascular Access System are the Ellipsys Catheter, the Ellipsys Crossing Needle, and the Ellipsys Power Controller. The Crossing Needle and Catheter are single-use, sterile disposables. The Ellipsys Power Controller is a reusable, non-sterile portable electronic console that is packaged and provided separately. · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00763000496982), received between Dec 5, 2023 and Dec 5, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Difficult to Remove” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Difficult to Remove1

Patient problems

  • Hematoma1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 5, 2023Difficult to Remove; Difficult to Remove

    A PHYSICIAN WAS ATTEMPTING TO USE AN ELLIPSYS CATHETER. THE IFU WAS FOLLOWED. IT WAS REPORTED THE PHYSICIAN DID NOT ACTIVATE THE DEVICE. INITIAL ACCESS (THROUGH PERFORATOR INTO RADIAL ARTERY) WAS PERFORMED. PLACEMENT OF 'GAP' IN DEVICE WAS ATTEMPTED, TO DRAW BACK THE RADIAL ARTERY TOWARDS THE PERFORATOR. THE PHYSICIAN WITHDREW THE ELLIPSYS DEVICE BACK AT LEAST 20MM. DURING THE INITIAL PLACEMENT , RESISTANCE OF THE DEVICE COULD NOT BE 'FELT' IN THE RADIAL ARTERY UPON INITIAL PULLBACK. SEVERAL ATTEMPTS WERE MADE, THE DEVICE WAS NOT ACTIVATED DUE TO NO ¿FEEL¿ OF THE FOOTPLATE WITHIN THE RADIAL ARTERY WAS FELT. THE DEVICE WAS ROTATED TO BETTER VISUALIZE IT UNDER ULTRASOUND. ON THE THIRD ATTEMPT THE PHYSICIAN WITHDREW THE DEVICE FROM THE PATIENT WITH FORCE, AND A LARGE HAEMATOMA WAS FORMED, THE TREATMENT WAS NOT PERFORMED. FASCIOTOMY SURGICAL REPAIR FOR A HEMATOMA WAS PERFORMED.

    Patient problems: Hematoma

    MAUDE report 18266155 ↗

Other Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access devices

All Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.